- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01083472
Repair of Challenging Abdominal Wall Defects: Strattice(TM) TM in Abdominal Wall Repair (StAR) (StAR)
A Multicenter, Prospective, Single-Blind, Randomized, Controlled Study of the Repair of Challenging Abdominal Wall Defects: Strattice(TM) TM in Abdominal Wall Repair
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a prospective, multicenter, single-blind, randomized, longitudinal, cross-over evaluation of the repair of challenging abdominal wall defects using Strattice(TM) TM or standard surgical repair. These abdominal wall defects can be acute or chronic, and include midline, transverse (including flank) as well as Pfannenstiel incisions. The skin may be closed (fascial dehiscence or incisional hernia) or open (patient with open abdomen or acute fascial dehiscence) with or without evisceration. Patients randomized to the control group who require a re-operation to perform the planned final repair or due to failure of the initial repair within 12 months, will be offered repair with Strattice™ TM (i.e. "crossed over") or if such repair not performed, the patient will have completed the study. An adaptive study design will be used to validate the initial conditional power of the study and a balanced randomization, based upon the three conditions (type of defect [dehiscence, hernia repair or open abdomen], morbidity [POSSUM score] and time since exposure of abdominal fascia/viscera) will be used to equally distribute subjects between groups.
The primary endpoint of this study is hernia occurrence at 12 months post repair and secondary endpoints include re-operation for abdominal wall repair within 12 months, incidence of complications requiring intervention(medical or surgical) within the first 30 days after repair,, length of hospitalization and resource utilization, and all cause mortality.
Subjects will be enrolled and randomized to receive Strattice(TM) TM reinforcement of repair or standard of care repair (i.e. suture alone or suture with absorbable mesh) and followed at set timepoints to observe incision site repair for surgical site events, including reoperation and hernia occurrence.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Amiens, France
- CHU Amiens Hopital Nord
-
Paris, France
- Hôpital de la Pitié-Salpêtrière
-
Reims, France
- CHU Robert Debré
-
-
-
-
-
Aachen, Germany
- Universitätsklinikum Aachen
-
Berlin, Germany
- Unfallkrankenhaus Berlin
-
Bochum, Germany
- St. Josef-Hospital
-
Düsseldorf, Germany
- Universitatsklinikum Dusseldorf
-
Frankfurt am Main, Germany
- Klinikum und Fachbereich Medizin der Johann Wolfgang Goethe Universitat
-
Giessen, Germany
- Universitätsklinikum Giessen und Marburg GmbH
-
Hamburg, Germany
- Universitätsklinikum Hamburg-Eppendorf
-
Hausham, Germany
- Krankenhaus Agatharied GmbH
-
Heidelberg, Germany
- Universitätsklinikum Heidelberg
-
Heidelberg, Germany
- Krankenhaus Salem der Evang. Stadtmission Heidelberg
-
Konstanz, Germany
- Klinikum Konstanz
-
Köln, Germany
- Kliniken der Stadt Koln
-
München, Germany
- LMU Klinikum der Universität München
-
München, Germany
- Technischen Universität München - Klinikum rechts der Isar
-
Neuss, Germany
- Lukaskrankenhaus
-
Straubing, Germany
- Klinikum St Elisabeth Straubing GmbH
-
-
-
-
-
Bologna, Italy
- St Orsola-Malpighi University Hospital
-
-
-
-
-
Den Haag, Netherlands
- Haga ziekenhuis
-
Maastricht, Netherlands
- Academisch Ziekenhuis Maastrict
-
Rotterdam, Netherlands
- Erasmus Medisch Centrum
-
-
-
-
-
Barcelona, Spain
- Hospital Universitari del Mar
-
-
-
-
-
Birmingham, United Kingdom
- Sandwell General Hospital
-
Inverness, United Kingdom
- Raigmore Hospital
-
Manchester, United Kingdom
- Manchester Royal Infirmary
-
Solihull, United Kingdom
- Heart of England NHS Trust
-
Upton, Wirral, United Kingdom
- Arrowe Park Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- adults (18years of age or older) who is able to provide written informed consent for study participation
- has need of surgical intervention for repair of (potentially) contaminated abdominal wall defect of >3cm and <22cm in length, where the viscera have not been exposed for more than 15 days in case of open abdomen(skin and fascia open).
- Is willing and able to return for all scheduled & required study visit.
Exclusion Criteria: at the time of randomization
- severe systemic sepsis
- frank pus in the wound, a fistula that will not be closed at the time of surgery or intra-abdominal abscess in surgical area,
- ongoing necrotizing pancreatitis,
- Is on chronic immunosuppressive therapy, or other medication that influences wound healing
- requires only short-term temporary closure,
- requires a synthetic, non-absorbable mesh to close the abdominal wall defect
- is unable to undergo general anesthesia,
- has other major organ system dysfunction or disorder that would jeopardize subject completing the 24 month study.
- Is unable to undergo an MRI scan
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Strattice(TM) TM repair
Strattice(TM) TM will be placed in the intraperitoneal or retrorectus position to support the repair of abdominal wall defect
|
Strattice(TM) TM will be used to support the repair of abdominal wall defect
|
Active Comparator: Standard of Care repair
Abdominal wall defect will be repaired using current standard of care techniques of either suture alone or suture with absorbable surgical mesh
|
Abdominal wall defect will be repaired with suture alone or absorbable mesh with suture
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hernia Occurrence
Time Frame: Month 12 after repair
|
Hernia occurrence will be assessed by clinical evaluation.
At Month 12 and at any time during the study if hernia occurrence is clinically suspected, a magnetic resonance image (MRI) will be obtained.
|
Month 12 after repair
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Angus JM Watson, Raigmore Hospital, Inverness Scotland, National Health Service, UK
- Principal Investigator: Berndt Reith, Klinikum Konstanz, Konstanz Germany
- Study Chair: Johannes Jeekel
Publications and helpful links
General Publications
- van't RM, De Vos Van Steenwijk PJ, Bonjer HJ, Steyerberg EW, Jeekel J. Incisional hernia after repair of wound dehiscence: incidence and risk factors. Am Surg. 2004 Apr;70(4):281-6.
- Webster C, Neumayer L, Smout R, Horn S, Daley J, Henderson W, Khuri S; National Veterans Affairs Surgical Quality Improvement Program. Prognostic models of abdominal wound dehiscence after laparotomy. J Surg Res. 2003 Feb;109(2):130-7. doi: 10.1016/s0022-4804(02)00097-5.
- Van Geldere D. One hundred years of abdominal wound dehiscence and nothing has changed. Hernia 2000; 4:302-4.
- Murugappan K, Gomes F, Waxman B. Abdominal wound dehiscence - who is really at risk? ANZ J Surg 2009; 79(S1):A25
- Gislason H, Viste A. Closure of burst abdomen after major gastrointestinal operations--comparison of different surgical techniques and later development of incisional hernia. Eur J Surg. 1999 Oct;165(10):958-61. doi: 10.1080/110241599750008071.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LFC2009.01.01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hernia
-
University of NebraskaLifeCellCompletedHiatal Hernia | Esophageal Hernia | Hernia, Esophageal | Hernia, Paraesophageal | Paraesophageal Hiatal Hernia | Sliding Esophageal Hernia | Sliding Hiatal HerniaUnited States
-
Advanced Medical Solutions Ltd.CompletedInguinal Hernia | Hernia | Femoral Hernia | Groin HerniaUnited States
-
Medtronic - MITGCompletedInguinal Hernia | Ventral HerniaUnited States
-
Mette Astrup MadsenCompletedInguinal Hernia | Femoral HerniaDenmark
-
W.L.Gore & AssociatesRecruitingHernia, Hiatal | Hernia, Diaphragmatic | Hernia, Ventral | Incisional HerniaUnited States
-
Hobart HarrisWithdrawnHernia | Ventral Hernia | Abdominal Hernia
-
Anne Arundel Health System Research InstituteMedtronic - MITGCompletedGrade I Ventral Hernia | Grade II Ventral HerniaUnited States
-
Foregut Research FoundationNot yet recruitingParaesophageal Hernia | Large Hiatal HerniaUnited States
-
AbbVieNot yet recruiting
-
Prisma Health-UpstateRecruiting
Clinical Trials on Strattice(TM) Reconstructive Tissue Matrix
-
LifeCellTerminatedPatients With Breast Cancer Requiring Mastectomy and Suitable for ReconstructionItaly
-
RTI SurgicalCompletedVentral HerniaUnited States
-
Stryker Trauma GmbHLifeCellCompleted
-
Aarhus University HospitalNovo Nordisk A/S; University of Aarhus; LifeCellCompletedAbdominal Donor-siteDenmark
-
University of BirminghamLifeCellCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...LifeCellCompleted